These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21956197)

  • 21. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
    Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
    J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
    Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z
    Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice.
    Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodström-Tullberg M; Kärre K; Höglund P
    J Immunol; 2010 Mar; 184(5):2272-80. PubMed ID: 20130214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
    Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
    J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.
    Lin J; Chan WFN; Boon L; Anderson CC
    Front Immunol; 2018; 9():837. PubMed ID: 29740442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
    Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
    J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
    Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
    Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to the induction of mixed chimerism in spontaneously diabetic NOD mice depends on the CD40/CD154 pathway and donor MHC disparity.
    Luo B; Wu T; Pan Y; Sozen H; Hao J; Zhang Y; Sutherland DE; Hering BJ; Guo Z
    Ann N Y Acad Sci; 2007 Apr; 1103():94-102. PubMed ID: 17376827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
    Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
    Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
    Leijon K; Hillörn V; Bergqvist I; Holmberg D
    J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved.
    Moore DJ; Huang X; Lee MK; Lian MM; Chiaccio M; Chen H; Koeberlein B; Zhong R; Markmann JF; Deng S
    Transpl Int; 2004 Jun; 17(5):261-9. PubMed ID: 15138669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.